Navigation Links
InspireMD Reports Record Third Quarter 2011 Operating and Financial Results and Strategic Update
Date:11/15/2011

eceded by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential" or similar words. Forward-looking statements are not guarantees of future performance, are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company's control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) market acceptance of our existing and new products, (ii) negative clinical trial results or lengthy product delays in key markets, (iii) an inability to secure regulatory approvals for the sale of our products, (iv) intense competition in the medical device industry from much larger, multi-national companies, (v) product liability claims, (vi) our limited manufacturing capabilities and reliance on subcontractors for assistance, (vii) insufficient or inadequate reimbursement by governmental and other third party payors for our products, (viii) our efforts to successfully obtain and maintain intellectual property protection covering our products, which may not be successful, (ix) legislative or regulatory reform of the healthcare system in both the U.S. and foreign jurisdictions, (x) our reliance on single suppliers for certain product components, (xi) the fact that we will need to raise additional capital to meet our business requirements in the future and that such capital raising may be costly, dilutive or difficult to obtain and (xii) the fact that we conduct business in multiple foreign jurisdictions, exposing us to foreign currency exchange rate fluctuations, logistical and communications challenges, burdens and costs of compliance with foreign laws and political and economic instability in each jurisdiction. More
'/>"/>
SOURCE InspireMD
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. InspireMD Announces the Enrollment of the 1st Patient in the MGuard iMOS Registry, the Registry Will Enroll 1000 Patients
2. For the First Time, at EuroPCR, InspireMD Will Provide a Sneak Preview of the Next Generation MGuard Prime(R), a State of the Art Net Protective Cobalt Chromium Stent System
3. InspireMD Becomes a Supporting Organization in the Growing Stent for Life Initiative
4. InspireMD Boosts MGuard Production Capacity
5. InspireMD to Commence Trading as a Public Company Under Ticker Symbol "NSPR"
6. InspireMD to Participate in Benchmark Company, LLC 2011 One-On-One Investor Conference
7. InspireMD Increases Geographic Penetration; MGuard Stent is Now Available in India
8. InspireMD Promotes MGuard™ at the EuroPCR 2011 Exhibition and Conference in Paris This Week
9. InspireMD Announces Year-to-Date 2011 Progress
10. InspireMD Broadens Global Distribution Network; Signs Distributor for the Russian Federation
11. Sol J. Barer, Ph.D. Joins InspireMD Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... 25, 2014  Breckenridge Pharmaceutical, Inc. announced today ... agreement with Pii (Pharmaceutics International, Inc.) ( ... and Pii expect to develop and commercialize several ... Pii will develop, manufacture and supply the products, ... under its own label.  The drugs, comprised of ...
(Date:11/26/2014)... , Nov. 25, 2014 Halozyme Therapeutics, Inc. ... Piper Jaffray Healthcare Conference in New York ... a.m. PDT . Dr. Helen Torley , President ... The presentation will be webcast through the "Investors" section ... recording will be made available for 90 days following the ...
(Date:11/24/2014)...  Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) announced today ... and update at the Piper Jaffray 26 th Annual ... Eastern Time (5:30 a.m. Pacific Time), at The New York ... A live audio webcast of the presentation will be ... www.arenapharm.com . A replay of the presentation will be ...
Breaking Medicine Technology:Breckenridge Pharmaceutical signs Multi-Product Generic Agreement with Pharmaceutics International, Inc. 2Halozyme Therapeutics To Present At The Piper Jaffray Healthcare Conference 2Arena Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 2Arena Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 3
(Date:11/26/2014)... (PRWEB) November 26, 2014 With a ... surgeon Dr. Steven Meier has enhanced the user ... current and prospective patients an online destination for orthopedic ... excited to present the new and improved version of ... make it easier than ever for current and prospective ...
(Date:11/26/2014)... 26, 2014 GI for Life announced ... reductions in prices of their popular nutritional supplements: ... D3 . Discounts of 40% will be offered ... for Life’s proprietary ColoVite supplement is a scientifically formulated ... colon health. One easy-to-take colon vitamin with ALL the ...
(Date:11/26/2014)... 2014 Sonru, the video interviewing specialist, ... Operating Officer and Chief Marketing Officer, in addition to ... , Jeff Jones has been appointed as Chief Operating ... the role of Chief Marketing Officer. , Mr Jones ... 25-year career includes senior roles with The Walt Disney ...
(Date:11/26/2014)... 2014 Anthropologists have identified concrete ... and stopping Ebola, improve international support, and pave ... in West Africa. , The report, “Strengthening ... Anthropologists Offer Insights,” will be made public during ... Association (AAA), Fri., Dec. 5, 11 a.m., at ...
(Date:11/26/2014)... 26, 2014 Medical suction and vacuum ... of 5. This score represents steady growth in the ... to 2014 as a result of swelling demand for ... which are largely considered nondiscretionary. IBISWorld market research analyst, ... have some degree of flexibility, given the low level ...
Breaking Medicine News(10 mins):Health News:Los Angeles Orthopedic Surgeon Dr. Steven Meier Announces Relaunch Of Practice Website 2Health News:GI For Life Slashes Prices by 40% on Liposomal Vitamin D3 and ColoVite Colon Health Formula for a Limited Time 2Health News:Sonru Expansion continues with appointment of new executive team and opening of new London base 2Health News:Anthropologists Release Recommendations, Better Practices to Contain Ebola 2Health News:Anthropologists Release Recommendations, Better Practices to Contain Ebola 3Health News:Medical Suction & Vacuum Products Procurement Category Market Research Report from IBISWorld has Been Updated 2Health News:Medical Suction & Vacuum Products Procurement Category Market Research Report from IBISWorld has Been Updated 3Health News:Medical Suction & Vacuum Products Procurement Category Market Research Report from IBISWorld has Been Updated 4
... Karolinska Institutet sheds light on the pathological course of ... to display amyloids demonstrable with a PET scanner has ... after death. One pathological characteristic of Alzheimer,s ... proteins to form amyloid plaques. However, it is not ...
... , TUESDAY, Dec. 14 (HealthDay News) -- Babies born ... of stress hormones, decreased muscle tone and other neurological and ... are that [the infants] are either more sensitive to stress ... less able to shut down their stress response," lead investigator ...
... A one-year follow-up study on seniors who participated in a ... as savings for the healthcare system. The research, conducted at ... Health and the University of British Columbia, is published today ... study is the first to examine whether both cognitive and ...
... News) -- About 40 percent of patients with incurable ... treatments, finds a new study. German researchers asked ... gliomas (tumors) about their use of alternative therapies. ... homeopathy, 31 percent used vitamin supplements and 29 percent ...
... Reporter , MONDAY, Dec. 13 (HealthDay News) -- Taxing ... minimal weight loss, although the revenues generated could be ... Adding to a spate of recent studies examining ... Duke-National University of Singapore (NUS) Graduate Medical School looked ...
... Expression of a toxic RNA that leads to Fragile X ... according to new research from U-M Medical School scientists., In ... Of Science Genetics, U-M,s Peter K. Todd, M.D., Ph.D., led ... toxic messenger RNA (mRNA) seen in the brains of those ...
Cached Medicine News:Health News:Unique case study on Alzheimer's disease 2Health News:Depression During Pregnancy Might Affect Baby 2Health News:Strength training for seniors provides cognitive function, economic benefits: VCH-UBC study 2Health News:Many Brain Tumor Patients Turn to Alternative Therapies 2Health News:Taxing Sodas Won't Spur Much Weight Loss, Study Says 2Health News:Taxing Sodas Won't Spur Much Weight Loss, Study Says 3Health News:U-M researchers discover way to block neurodegeneration in an adult form of Fragile X syndrome 2
... new age of non-surgical facial contouring materials. ... long-term results for various applications with exceptional ... superior versatility for a wide variety of ... saves time and money for both you ...
... Response is a whole blood ... be used at the point-of-care. ... screen and data management features, ... options. QC and operator lockout ...
... a revolutionary scientific breakthrough for controlling unsightly ... Cream permits you to spot reduce in ... can rid yourself of those unwanted lumps ... to your thigh, waist, tummy, or chin ...
... has been developed specifically to fight Cellulite ... and hips. It does this by stimulating ... fluids in your body, which then are ... daily, for about 15 minutes each treatment. ...
Medicine Products: